Sartorius AG - Company Profile
Powered by 
All the sales intelligence you need on Sartorius AG in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Sartorius AG fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Sartorius AG.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Sartorius AG (Sartorius) is a medical device company that offers laboratory and process technology equipment. The company's product portfolio includes cell lines; cell culture media; reagents; bioreactors; technologies for the separation, purification, and concentration of biological intermediates and end products; solutions for storage and transportation; laboratory balances; pipettes; lab water systems; and consumables, such as filters and microbiological test kits; among others. It also offers services such as bioprocess consulting and engineering, cell culture media services, biologics testing, instrument service, and validation services. Sartorius serves pharmaceutical and biotechnology companies, academic research facilities, and quality control labs in the chemical and food industries. The company's products are used in applications such as drug development, biopharmaceutical manufacturing, and quality control. Sartorius is headquartered in Gottingen, Niedersachsen, Germany.
Headquarters
Germany
Address
Otto-Brenner-Str. 20, Goettingen, Niedersachsen, 37079
Website
www.sartorius.com
Telephone
49 551 3080
No of Employees
12,627
Industry
Medical Equipment
Ticker Symbol & Exchange
SRT (ETR)
Revenue (2024)
$4.0B
4.7%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
84.5%
(2024 vs 2023)
Market Cap*
$17.7B
Net Profit Margin (2024)
XYZ
76.6%
(2024 vs 2023)
* As of and is in US$
Sartorius AG premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Laboratory Products and Services: | Instrument Services | Ambr |
| Quality Control: | Validation Services | Octet |
| Moisture and NIR Analysers | Process Optimization | |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Corporate Changes/Expansions | In September, the company expanded its Sartorius Stedim Biotech in Illkirch, near Strasbourg, France. |
| 2025 | Acquisitions/Mergers/Takeovers | In July, the company acquired MatTek Corp, including Visikol Inc., from BICO Group AB. |
| 2025 | Contracts/Agreements | In March, the company entered into a partnership with Mycenax to enhance biopharmaceutical manufacturing solutions and expand CDMO services globally. |
Competitor Comparison
| Key Parameters | Sartorius AG | General Electric Co | Thermo Fisher Scientific Inc | Danaher Corp | Merck KGaA |
|---|---|---|---|---|---|
| Headquarters | Germany | United States of America | United States of America | United States of America | Germany |
| City | Goettingen | Cincinnati | Waltham | Washington | Darmstadt |
| State/Province | Niedersachsen | Ohio | Massachusetts | WashingtonD.C. | Hessen |
| No. of Employees | 12,627 | 57,000 | 125,000 | 58,000 | 62,461 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Lothar Kappich | Chairman | Executive Board | 2007 | 69 |
| Michael Grosse | Chief Executive Officer | Senior Management | 2025 | 59 |
| Florian Funck | Chief Financial Officer | Senior Management | 2024 | 55 |
| Rene Faber | Head - Bioprocess Solutions Division | Senior Management | 2019 | 51 |
| Alexandra Gatzemeyer | Head - Lab Products and Services Division | Senior Management | 2023 | 47 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer